Unlock stock picks and a broker-level newsfeed that powers Wall Street.
Shanghai - Delayed Quote CNY

Sichuan Hebang Biotechnology Corporation Limited (603077.SS)

Compare
1.6500
-0.1800
(-9.84%)
At close: 3:00:03 PM GMT+8
Loading Chart for 603077.SS
  • Previous Close 1.8300
  • Open 1.7800
  • Bid 1.6500 x --
  • Ask 1.6600 x --
  • Day's Range 1.6500 - 1.7800
  • 52 Week Range 1.6100 - 2.4300
  • Volume 136,315,033
  • Avg. Volume 72,221,304
  • Market Cap (intraday) 14.572B
  • Beta (5Y Monthly) 0.30
  • PE Ratio (TTM) 27.50
  • EPS (TTM) 0.0600
  • Earnings Date --
  • Forward Dividend & Yield 0.02 (1.09%)
  • Ex-Dividend Date Oct 15, 2024
  • 1y Target Est --

Sichuan Hebang Biotechnology Corporation Limited provides agricultural, chemical, and new material products. It offers biological pesticides, biological veterinary drugs, and methionine products; and sodium carbonate, ammonium chloride, soda ash, diglyphosate, glyphosate, and brine. The company also provides original glass and smart glass, special glass, low-e coated glass, and photovoltaic packaging materials and products, as well as photovoltaic glass and module products. In addition, it engages in the supply of oil and gas. The company was formerly known as SichuanHebang Biotechnology Co.,Ltd. and changed its name to Sichuan Hebang Biotechnology Corporation Limited in April 2021. Sichuan Hebang Biotechnology Corporation Limited was founded in 2002 and is based in Leshan, China.

www.hebang.cn

7,169

Full Time Employees

December 31

Fiscal Year Ends

Chemicals

Industry

Recent News: 603077.SS

View More

Performance Overview: 603077.SS

Trailing total returns as of 4/7/2025, which may include dividends or other distributions. Benchmark is SSE Composite Index (000001.SS) .

YTD Return

603077.SS
19.12%
SSE Composite Index (000001.SS)
7.61%

1-Year Return

603077.SS
29.39%
SSE Composite Index (000001.SS)
0.89%

3-Year Return

603077.SS
50.43%
SSE Composite Index (000001.SS)
4.33%

5-Year Return

603077.SS
15.22%
SSE Composite Index (000001.SS)
9.78%

Compare To: 603077.SS

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 603077.SS

View More

Valuation Measures

Annual
As of 4/3/2025
  • Market Cap

    16.16B

  • Enterprise Value

    17.03B

  • Trailing P/E

    31.88

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    1.66

  • Price/Book (mrq)

    0.86

  • Enterprise Value/Revenue

    1.85

  • Enterprise Value/EBITDA

    27.11

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    5.28%

  • Return on Assets (ttm)

    1.39%

  • Return on Equity (ttm)

    2.31%

  • Revenue (ttm)

    9.2B

  • Net Income Avi to Common (ttm)

    485.52M

  • Diluted EPS (ttm)

    0.0600

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    2.57B

  • Total Debt/Equity (mrq)

    17.75%

  • Levered Free Cash Flow (ttm)

    -492.2M

Research Analysis: 603077.SS

View More

Company Insights: 603077.SS

Research Reports: 603077.SS

View More

People Also Watch